UNITAID / WORLD CHAGAS DAY
13-Apr-2022
00:02:42
Ahead of the World Chagas Day, Unitaid says that it remains committed to improving access to testing and treatment to reduce mother-to-child transmission of Chagas. UNITAID
Subject to the Terms of Usages of UNifeed, UNifeed materials are available free of charge for news purposes only. UNifeed materials may not be sold or redistributed to third parties without the prior written consent of the UN or the UN entity which is source of the UNifeed material. All users of UNifeed materials must provide due credit to the United Nations or any UN entity source(s) in their use and broadcast of UNifeed materials.
Size
Format
Acquire
DESCRIPTION
STORY: UNITAID / WORLD CHAGAS DAY
TRT: 2:42
SOURCE: UNITAID
RESTRICTIONS: NONE
LANGUAGE: PORTUGUESE / NATS
DATELINE: 13 APRIL 2022, GENEVA, SWITZERLAND / FILE
TRT: 2:42
SOURCE: UNITAID
RESTRICTIONS: NONE
LANGUAGE: PORTUGUESE / NATS
DATELINE: 13 APRIL 2022, GENEVA, SWITZERLAND / FILE
SHOTLIST
FILE – FIOCRUZ - FEBRUARY 2022 – BRAZIL
1. Close up, interior, Posters and artwork on Chagas.
2. Close up, an insect vector of the Trypanosoma cruzi (T. cruzi) parasite.
FILE – FIOCRUZ - SANTIAGO, CHILE
3. Various shots, insect vectors of the Trypanosoma cruzi (T. cruzi) parasite at the Public Health Institute of Chile in Santiago, Chile (Instituto de Salud Pública de Chile en Santiago).
13 APRIL 2022, GENEVA, SWITZERLAND
4. SOUNDBITE (Portuguese) Mauricio Cysne, Director of External Relations, Unitaid:
“Unitaid is proud to partner with the Brazilian Ministry of Health and Fiocruz to improve access to affordable diagnosis, treatment and care for women and newborns with Chagas disease. In Latin America, Chagas disease causes more deaths than any other disease caused by a parasite, including malaria, with an estimated 75 million people at risk. Unitaid supports actions in Brazil, Bolivia, Colombia, and Paraguay to improve screening and treatment of Chagas disease to limit mother-to-child transmission. Thus, avoiding hospitalizations and deaths from this insidious disease throughout the region.”
FILE – FIOCRUZ - SANTIAGO, CHILE
5. Med shot, woman examining insect under a microscope.
6. Close up, woman examining insect under a microscope.
FILE – FIOCRUZ - FEBRUARY 2022 – BRAZIL
7. Various shots, using a Medtronic REVEAL® cardiac monitor, a medical staff interrogates a patient's implantable cardioverter defibrillator (ICD) then prints the results.
8. Various shots, a nurse gives a presentation on Chagas, including what insect vectors of the Trypanosoma cruzi (T. cruzi) parasite look like and how people can protect themselves.
1. Close up, interior, Posters and artwork on Chagas.
2. Close up, an insect vector of the Trypanosoma cruzi (T. cruzi) parasite.
FILE – FIOCRUZ - SANTIAGO, CHILE
3. Various shots, insect vectors of the Trypanosoma cruzi (T. cruzi) parasite at the Public Health Institute of Chile in Santiago, Chile (Instituto de Salud Pública de Chile en Santiago).
13 APRIL 2022, GENEVA, SWITZERLAND
4. SOUNDBITE (Portuguese) Mauricio Cysne, Director of External Relations, Unitaid:
“Unitaid is proud to partner with the Brazilian Ministry of Health and Fiocruz to improve access to affordable diagnosis, treatment and care for women and newborns with Chagas disease. In Latin America, Chagas disease causes more deaths than any other disease caused by a parasite, including malaria, with an estimated 75 million people at risk. Unitaid supports actions in Brazil, Bolivia, Colombia, and Paraguay to improve screening and treatment of Chagas disease to limit mother-to-child transmission. Thus, avoiding hospitalizations and deaths from this insidious disease throughout the region.”
FILE – FIOCRUZ - SANTIAGO, CHILE
5. Med shot, woman examining insect under a microscope.
6. Close up, woman examining insect under a microscope.
FILE – FIOCRUZ - FEBRUARY 2022 – BRAZIL
7. Various shots, using a Medtronic REVEAL® cardiac monitor, a medical staff interrogates a patient's implantable cardioverter defibrillator (ICD) then prints the results.
8. Various shots, a nurse gives a presentation on Chagas, including what insect vectors of the Trypanosoma cruzi (T. cruzi) parasite look like and how people can protect themselves.
STORYLINE
Ahead of the World Chagas Day, Unitaid says that it remains committed to improving access to testing and treatment to reduce mother-to-child transmission of Chagas.
Up to seven million people worldwide are estimated to be infected with a disease that often presents no symptoms but can be life-threatening when left untreated.
World Chagas Day is on 14 April. It raises awareness of this neglected disease, for which fewer than 10 per cent of all those affected get diagnosed and only 1 percent receive appropriate care.
Often referred to as a “silent disease” because it causes no or few symptoms, the World Health Organization (WHO) has highlighted the critical need for increased screening, the lack of which poses a significant barrier to care for the 75 million people estimated to be at risk of infection.
In Latin America, where it is endemic, Chagas disease causes more deaths each year than any other parasitic disease including malaria. Many of those at highest risk are among the poorest and most marginalized populations.
Chagas disease is caused by the “Trypanosoma crusi” parasite, which is transmitted to humans through a bite from the triatomine insect, also known as the kissing bug. It can then be passed congenitally from mother to child, or through blood transfusion or organ donation.
Often referred to as a “silent disease” because it causes no or few symptoms, the World Health Organization (WHO) has highlighted the critical need for increased screening, the lack of which poses a significant barrier in access to care for the 75 million people estimated to be at risk of infection.
With more than a million women of childbearing age estimated to be infected with Chagas disease, preventing mother to child transmission is critical to slowing the spread of disease and averting illness.
Global health agency Unitaid, jointly with the Brazilian Ministry of Health, has committed to improve access to affordable point-of-care tests, better treatment and comprehensive care for women and their infants.
With systematic screening of women and babies, this work can substantially limit transmission and reduce the number of new infections each year, helping to avert more serious and costly health consequences later in life.
In 30 percent of all people chronically infected, Chagas disease causes severe heart and gastrointestinal complications including stroke, heart attack and sudden death when left untreated. The Pan American Health Organization (PAHO) estimates that Chagas disease accounts for more than US$600 million in healthcare-related costs each year.
Unitaid’s efforts, underway in Brazil, Bolivia, Colombia, and Paraguay, seek to demonstrate new approaches to testing, treatment and care for Chagas disease that will generate valuable evidence to facilitate the adoption of feasible and cost-effective health strategies for combatting Chagas disease across the region and globally.
While most cases still occur in Latin America, the disease is increasingly spreading to other geographies. People have now been diagnosed with Chagas disease in 44 countries across the Americas, Africa, Asia, Europe, and Oceania.
Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose, and treat diseases more quickly, cheaply, and effectively, in low- and middle-income countries.
Up to seven million people worldwide are estimated to be infected with a disease that often presents no symptoms but can be life-threatening when left untreated.
World Chagas Day is on 14 April. It raises awareness of this neglected disease, for which fewer than 10 per cent of all those affected get diagnosed and only 1 percent receive appropriate care.
Often referred to as a “silent disease” because it causes no or few symptoms, the World Health Organization (WHO) has highlighted the critical need for increased screening, the lack of which poses a significant barrier to care for the 75 million people estimated to be at risk of infection.
In Latin America, where it is endemic, Chagas disease causes more deaths each year than any other parasitic disease including malaria. Many of those at highest risk are among the poorest and most marginalized populations.
Chagas disease is caused by the “Trypanosoma crusi” parasite, which is transmitted to humans through a bite from the triatomine insect, also known as the kissing bug. It can then be passed congenitally from mother to child, or through blood transfusion or organ donation.
Often referred to as a “silent disease” because it causes no or few symptoms, the World Health Organization (WHO) has highlighted the critical need for increased screening, the lack of which poses a significant barrier in access to care for the 75 million people estimated to be at risk of infection.
With more than a million women of childbearing age estimated to be infected with Chagas disease, preventing mother to child transmission is critical to slowing the spread of disease and averting illness.
Global health agency Unitaid, jointly with the Brazilian Ministry of Health, has committed to improve access to affordable point-of-care tests, better treatment and comprehensive care for women and their infants.
With systematic screening of women and babies, this work can substantially limit transmission and reduce the number of new infections each year, helping to avert more serious and costly health consequences later in life.
In 30 percent of all people chronically infected, Chagas disease causes severe heart and gastrointestinal complications including stroke, heart attack and sudden death when left untreated. The Pan American Health Organization (PAHO) estimates that Chagas disease accounts for more than US$600 million in healthcare-related costs each year.
Unitaid’s efforts, underway in Brazil, Bolivia, Colombia, and Paraguay, seek to demonstrate new approaches to testing, treatment and care for Chagas disease that will generate valuable evidence to facilitate the adoption of feasible and cost-effective health strategies for combatting Chagas disease across the region and globally.
While most cases still occur in Latin America, the disease is increasingly spreading to other geographies. People have now been diagnosed with Chagas disease in 44 countries across the Americas, Africa, Asia, Europe, and Oceania.
Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose, and treat diseases more quickly, cheaply, and effectively, in low- and middle-income countries.
Category
Topical Subjects
Source
Alternate Title
unifeed220413f